Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nektar Therapeutics

0.8968
+0.08149.98%
Post-market: 0.93000.0332+3.70%19:58 EDT
Volume:2.54M
Turnover:2.27M
Market Cap:165.42M
PE:-1.07
High:0.9500
Open:0.8998
Low:0.8421
Close:0.8154
Loading ...

B. Riley Starts Nektar Therapeutics With Buy Rating, $4 Price Target

MT Newswires Live
·
08 Jan

U.S. RESEARCH ROUNDUP-GE Healthcare, Summit Materials, Tapestry

Reuters
·
08 Jan

Nektar Therapeutics : B. Riley Initiates Coverage With Buy Rating; Price Target $4

THOMSON REUTERS
·
08 Jan

Nektar initiated with a Buy at B. Riley

TIPRANKS
·
08 Jan

Nektar Therapeutics (NKTR) Gets a Buy from B.Riley Financial

TIPRANKS
·
08 Jan

Institutional investors have a lot riding on Nektar Therapeutics (NASDAQ:NKTR) with 68% ownership

Simply Wall St.
·
04 Jan

Promising Future for Nektar Therapeutics: Innovative Approach in Autoimmune Disease Treatment with Rezpegaldesleukin

TIPRANKS
·
12 Dec 2024

HC Wainwright Initiates Nektar Therapeutics at Buy With $6.50 Price Target

MT Newswires Live
·
10 Dec 2024

Nektar initiated with a Buy at H.C. Wainwright

TIPRANKS
·
10 Dec 2024

Nektar Therapeutics Announces Nktr-255 Following Cd19-Directed CAR-T Therapy Enhanced Complete Response Rates in Patients With Relapsed or Refractory Large B-Cell Lymphoma at the 66TH Annual Ash Meeting

THOMSON REUTERS
·
08 Dec 2024

Nektar Therapeutics Announces NKTR-255 Following CD19-directed CAR-T Therapy Enhanced Complete Response Rates in Patients with Relapsed or Refractory Large B-cell Lymphoma at the 66th Annual ASH Meeting

PR Newswire
·
08 Dec 2024

Press Release: Ampersand Capital Partners Completes Acquisition of Nektar Therapeutics' PEG Reagent Manufacturing Business, Launching Newly Branded Gannet BioChem

Dow Jones
·
02 Dec 2024

Nektar presents preclinical data on NKTR-422 at ACR conference

TIPRANKS
·
19 Nov 2024

Nektar Therapeutics Presents First Preclinical Data from Novel CSF-1 Program, NKTR-422, at 2024 American College of Rheumatology (ACR) Convergence

PR Newswire
·
19 Nov 2024

Nektar Therapeutics (NASDAQ:NKTR) Just Reported And Analysts Have Been Lifting Their Price Targets

Simply Wall St.
·
10 Nov 2024

Nektar Therapeutics Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.
·
09 Nov 2024